Authors: Eura, M Chikamatsu, K Katsura, F Obata, A Sobao, Y Takiguchi, M Song, YS Appella, E Whiteside, TL DeLeo, AB

Citation: M. Eura et al., A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck, CLIN CANC R, 6(3), 2000, pp. 979-986

Authors: Katsura, F Eura, M Chikamatsu, K Oiso, M Yumoto, E Ishikawa, T

Citation: F. Katsura et al., Analysis of individual specific cytotoxic T lymphocytes for two MAGE-3-derived epitopes presented by HLA-A24, JPN J CLIN, 30(3), 2000, pp. 117-121

Authors: Obata, A Eura, M Sasaki, J Saya, H Chikamatsu, K Tada, M Iggo, RD Yumoto, E

Citation: A. Obata et al., Clinical significance of p53 functional loss in squamous cell carcinoma ofthe oropharynx, INT J CANC, 89(2), 2000, pp. 187-193

Authors: Chikamatsu, K Nakano, K Storkus, WJ Appella, E Lotze, MT Whiteside, TL DeLeo, AB

Citation: K. Chikamatsu et al., Generation of anti-p53 cytotoxic T lymphocytes from human peripheral bloodusing autologous dendritic cells, CLIN CANC R, 5(6), 1999, pp. 1281-1288

Authors: Chikamatsu, K Reichert, TE Kashii, Y Saito, T Kawashiri, S Yamamoto, E Whiteside, TL

Citation: K. Chikamatsu et al., Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice, INT J CANC, 82(4), 1999, pp. 532-537